Breaking News Instant updates and real-time market news.

MYGN

Myriad Genetics

$25.55

0.34 (1.35%)

16:59
08/08/17
08/08
16:59
08/08/17
16:59

Myriad Genetics reports Q4 adjusted EPS 30c, consensus 26c

Reports Q4 revenue $200.5M, consensus $193.74M. The company said, "This quarter we saw record demand for hereditary cancer tests and now have 86 percent of our hereditary cancer revenue under long-term contract, providing future stability upon which to build our growing portfolio of new products. Our diversification efforts showed continued success with new products representing greater than two-thirds of test volume and 28 percent of revenue in the fourth-quarter. Our strong progress on transforming the company leaves us well positioned to achieve our long-term strategic goals."

  • 08

    Aug

MYGN Myriad Genetics
$25.55

0.34 (1.35%)

03/13/17
SPHN
03/13/17
UPGRADE
SPHN
Overweight
Myriad Genetics upgraded to Overweight from Equal Weight at Stephens
03/28/17
DBAB
03/28/17
NO CHANGE
Target $15
DBAB
Sell
Zejula label removes upside catalyst for Myriad, says Deutsche Bank
Deutsche Bank analyst Dan Leonard says FDA approval of Tesaro's (TSRO) Zejula, with a "broad rather than biomarker-limited label," removes one potential upside catalyst for Myriad Genetics (MYGN). While some investors are surprised by the broad label, many had already discounted the possibility of a label that limited usage to biomarker positive patients, which would have benefited test-supplier Myriad, Leonard tells investors in a research note. The analyst keeps a Sell rating on Myriad with a $15 price target.
04/05/17
04/05/17
NO CHANGE

Myriad Genetics publishes pivotal studies for myPath melanoma test
Myriad Genetics has published the third clinical validation study and second clinical utility study for its myPath Melanoma test, which completes the reimbursement dossier for the product. The company will submit the reimbursement dossier to Medicare and private insurers three months earlier than expected. myPath Melanoma is an objective genetic test that measures 23 genes to help differentiate malignant melanoma from benign lesions. The third clinical validation was published in the journal Cancer Epidemiology, Biomarkers & Prevention. The study assessed the performance of the myPath Melanoma test in an independent cohort of 182 patients with melanocytic lesions against clinically proven outcomes. The results showed that the myPath Melanoma test had an overall diagnostic accuracy of 95% to effectively differentiate melanoma from benign lesions. The second clinical utility study was designed to evaluate changes in real world patient management based upon the myPath Melanoma test result. Results showed a 71% change in patient management from pre-test recommendations and an 81% reduction in biopsy site re-excisions for patients with a benign test result.
06/29/17
JPMS
06/29/17
NO CHANGE
Target $16
JPMS
Underweight
JPMorgan keeps Underweight rating, $16 target on Myriad Genetics
With the shares up 30% over the past month, JPMorgan analyst Tycho Peterson maintains an Underweight rating on Myriad Genetics with a $16 price target. While the company's pipeline "intriguing," it is not enough to offset a continued decline in the core hereditary cancer business, Peterson tells investors in a research note. He believes near-term catalysts could drive the stock "meaningfully higher or lower," and highlights the FY18 guidance in the Q4 earnings report as being the most significant upcoming event.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
12/10/18
12/10
15:17
12/10/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
12/10/18
12/10
15:16
12/10/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTZ

Hertz

$16.18

-0.4 (-2.41%)

15:10
12/10/18
12/10
15:10
12/10/18
15:10
Options
DOOM puts opened in Hertz »

DOOM puts opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEMI

Chembio Diagnostics

$6.35

0.01 (0.16%)

15:05
12/10/18
12/10
15:05
12/10/18
15:05
Hot Stocks
Breaking Hot Stocks news story on Chembio Diagnostics »

Cortina Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPAR

Spartan Motors

$7.31

0.16 (2.24%)

15:05
12/10/18
12/10
15:05
12/10/18
15:05
Hot Stocks
Spartan Motors director James Sharman buys almost 16K shares of company stock »

Spartan Motors director…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:05
12/10/18
12/10
15:05
12/10/18
15:05
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

ASNA

Ascena Retail

$2.96

-0.05 (-1.66%)

15:04
12/10/18
12/10
15:04
12/10/18
15:04
Options
Ascena Retail options imply 27.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

WBT

Welbilt

$13.01

0.03 (0.23%)

15:01
12/10/18
12/10
15:01
12/10/18
15:01
Periodicals
Breaking Periodicals news story on Welbilt »

Hedgeye names Welbilt to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCTY

Paylocity

$62.89

0.63 (1.01%)

14:59
12/10/18
12/10
14:59
12/10/18
14:59
Conference/Events
Paylocity management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

OMI

Owens & Minor

$7.14

0.18 (2.59%)

14:54
12/10/18
12/10
14:54
12/10/18
14:54
Hot Stocks
Owens & Minor names Joseph S. Pekala chief information officer »

Owens & Minor, Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVIA

Covia

$4.81

-0.45 (-8.56%)

14:50
12/10/18
12/10
14:50
12/10/18
14:50
Hot Stocks
Breaking Hot Stocks news story on Covia »

SailingStone Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFIX

Stitch Fix

$26.91

0.57 (2.16%)

14:49
12/10/18
12/10
14:49
12/10/18
14:49
Options
Stitch Fix options imply 30.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

AIG

AIG

$37.12

-0.77 (-2.03%)

14:45
12/10/18
12/10
14:45
12/10/18
14:45
Options
AIG call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

GRO

Agria

$0.00

(0.00%)

14:43
12/10/18
12/10
14:43
12/10/18
14:43
Hot Stocks
Agria agrees to pay $3M to settle fraud charges »

The SEC announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVA

Covanta

$15.44

-0.18 (-1.15%)

14:41
12/10/18
12/10
14:41
12/10/18
14:41
Conference/Events
Covanta management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TEX

Terex

$28.31

(0.00%)

14:39
12/10/18
12/10
14:39
12/10/18
14:39
Conference/Events
Terex management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TROW

T. Rowe Price

$91.92

-1.35 (-1.45%)

, WCG

WellCare

$235.10

-3.8 (-1.59%)

14:39
12/10/18
12/10
14:39
12/10/18
14:39
Hot Stocks
Breaking Hot Stocks news story on T. Rowe Price, WellCare »

T. Rowe Price reports…

TROW

T. Rowe Price

$91.92

-1.35 (-1.45%)

WCG

WellCare

$235.10

-3.8 (-1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSI

Stage Stores

$1.30

-0.09 (-6.47%)

14:39
12/10/18
12/10
14:39
12/10/18
14:39
Hot Stocks
Breaking Hot Stocks news story on Stage Stores »

Axar Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$263.03

-0.65 (-0.25%)

14:38
12/10/18
12/10
14:38
12/10/18
14:38
General news
Dow recovers loss of over 500 points, turns positive »

At time of writing, the…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$263.03

-0.65 (-0.25%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTES

Gates Industrial

$13.98

0.02 (0.14%)

14:38
12/10/18
12/10
14:38
12/10/18
14:38
Conference/Events
Gates Industrial management to meet with UBS »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

14:35
12/10/18
12/10
14:35
12/10/18
14:35
General news
Treasury Action: yields have mostly edged up as Wall Street recovers »

Treasury Action: yields…

GD

General Dynamics

$170.66

3.28 (1.96%)

14:31
12/10/18
12/10
14:31
12/10/18
14:31
Hot Stocks
General Dynamics awarded $346.5M contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

F

Ford

$8.49

-0.33 (-3.74%)

14:31
12/10/18
12/10
14:31
12/10/18
14:31
Periodicals
Ford in talks with workers at German plant about job cuts, Reuters reports »

Ford confirmed that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

VLRX

Valeritas

$0.36

0.0296 (9.03%)

14:27
12/10/18
12/10
14:27
12/10/18
14:27
Hot Stocks
Breaking Hot Stocks news story on Valeritas »

Empery Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NIO

NIO Inc.

$6.90

-0.1 (-1.43%)

14:25
12/10/18
12/10
14:25
12/10/18
14:25
Options
NIO Inc call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.